Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
All News
Headline News
Press Releases
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Ameresco to Announce Second Quarter 2025 Financial Results on August 4, 2025
From Ameresco, Inc.
Via Business Wire
Tickers AMRC
AdaptHealth Corp. Closes Transaction to Dispose of Certain Home Infusion Assets and Reduces Debt
From AdaptHealth Corp.
Via Business Wire
Tickers AHCO
Lineage to Report Second-Quarter 2025 Financial Results on August 6, 2025
From Lineage, Inc.
Via Business Wire
Tickers LINE
Smart Money Is Betting Big In MSFT Options
Via Benzinga
Tickers MSFT
Ascent Industries Co. Completes Sale of American Stainless Tubing, Finalizing Transformation to Pure-Play Specialty Chemicals Platform
From Ascent Industries Co.
Via Business Wire
Tickers ACNT
Agree Realty Announces Second Quarter 2025 Earnings Release Date and Conference Call Information
From Agree Realty Corporation
Via Business Wire
Tickers ADC
Gain Therapeutics Announces Completion of Target Enrollment in Phase 1b Clinical Study Evaluating GT-02287 in People With Parkinson’s Disease With or Without a GBA1 Mutation
From Gain Therapeutics, Inc.
Via GlobeNewswire
Tickers GANX
Lumen Technologies Advances Financial Strategy to Support AI-Era Infrastructure Growth
From Lumen Technologies
Via Business Wire
Tickers LUMN
Dyne Therapeutics Announces Proposed Public Offering of Common Stock
From Dyne Therapeutics, Inc.
Via GlobeNewswire
Tickers DYN
Crinetics to Showcase the Next Generation of Endocrinology Innovation at ENDO 2025 with Eight Presentations From its Deep Pipeline
From Crinetics Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers CRNX
INmune Bio, Inc. Announces Closing of Approximately $19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
From INmune Bio, Inc.
Via GlobeNewswire
Tickers INMB
Yorkville Acquisition Corp. Announces Closing of $172,500,000 Initial Public Offering, Including Full Exercise of Underwriters’ Over-Allotment Option
From Yorkville Acquisition Corp.
Via GlobeNewswire
Progress Software Acquires Nuclia, an Innovator in Agentic RAG AI Technology
From Progress Software Corporation
Via GlobeNewswire
Tickers PRGS
NodeOps Network $NODE Token Generation Event Sells Out in Minutes via Binance Wallet, Debuts Across Top Global Exchanges
Via Zexprwire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Clark Smith, President of Golden Years Financial, Interviewed on the Influential Entrepreneurs Podcast Discussing Retirement Lifestyle
Via Get News
Topics Economy Retirement
Exposures Interest Rates Pension
Top California Lender Welcomes New Investors to Fuel Expanded Lending Capacity
From Top California Lender
Via GlobeNewswire
Wavelength Training Launches AI-Powered Writing Course to Strengthen Corporate Communication Skills
Via Get News
Topics Artificial Intelligence
Tickers MSFT
Exposures Artificial Intelligence
Verastem Oncology Announces Nature Medicine Publication of the Results from the First-in-Human Phase 1 FRAME Study of Avutometinib in Combination with Defactinib in Solid Tumors, including Low-Grade Serious Ovarian Cancer
From Verastem Oncology
Via Business Wire
Tickers VSTM
Where Air Products Stands With Analysts
Via Benzinga
Tickers APD
What 11 Analyst Ratings Have To Say About Marathon Petroleum
Via Benzinga
Tickers MPC
What Analysts Are Saying About Federal Signal Stock
Via Benzinga
Tickers FSS
What Analysts Are Saying About Tronox Holdings Stock
Via Benzinga
Tickers TROX
Market Whales and Their Recent Bets on RCL Options
Via Benzinga
Tickers RCL
Market Whales and Their Recent Bets on WFC Options
Via Benzinga
Tickers WFC
Prestige Global Meeting Source Announces Strategic Leadership Additions with Appointment of First-Ever President and Welcomes New Executive Vice President of Sales
From Prestige Global Meeting Source
Via Business Wire
Hudson Pacific Provides Business Update
From Hudson Pacific Properties, Inc.
Via Business Wire
Tickers HPP
Neurogene Announces Registrational Trial Design for Embolden™ Study of NGN-401 Gene Therapy for Rett Syndrome
From Neurogene Inc.
Via Business Wire
Tickers NGNE
Dyne Therapeutics Secures Up to $275 Million in Debt Financing from Hercules Capital
From Dyne Therapeutics, Inc.
Via GlobeNewswire
Tickers DYN HTGC
Deep Dive Into United Therapeutics Stock: Analyst Perspectives (9 Ratings)
Via Benzinga
Tickers UTHR
American Healthcare REIT Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
Via Benzinga
Tickers AHR
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.